Vaccine Contract Manufacturing Market is expected to reach USD 5.10 billion by 2031
Introduction The global vaccine contract manufacturing market has gained strong momentum in recent years, driven by growing demand for vaccines, increased outsourcing by pharmaceutical companies, and the need for scalable and efficient production capabilities. Contract manufacturing organizations (CMOs) play a critical role in enabling vaccine manufacturers to focus on core activities such as research and marketing while leveraging external expertise and facilities for production. The post-pandemic era has further underlined the strategic importance of contract manufacturers in supporting global immunization initiatives. Market Overview In 2023, the global vaccine contract manufacturing market was valued at approximately USD 2.82 billion. It is projected to grow at a compound annual growth rate (CAGR) of 7.68% and reach around USD 5.10 billion by 2031. This growth is being fueled by a rising focus on immunization programs, government support, technological advancement...